Our Respiratory Expertise
Respiratory research is one of hVIVO's core therapeutic areas, with extensive experience supporting clinical development programmes across asthma, COPD, bronchiectasis, idiopathic pulmonary fibrosis (IPF), nasal polyposis, allergic rhinitis, and other atopic conditions. Through our integrated clinical, laboratory, recruitment, and consultancy capabilities, we provide end-to-end respiratory clinical trial solutions designed to support sponsors from early research through to clinical proof-of-concept and data generation.
.jpg)
Respiratory Clinical Trial Capabilities
hVIVO combines specialist respiratory expertise with one of Europe's largest volunteer and patient databases, comprising more than 400,000 active participants, including over 80,000 asthma patients and more than 26,000 atopic participants. Supported by a dedicated recruitment team focused on ongoing patient characterisation, this enables efficient enrolment and helps minimise screen failures across respiratory studies.
In addition to conventional respiratory clinical trials, hVIVO is recognised for its human challenge trial expertise and broader integrated drug development capabilities, which include clinical trial delivery, specialist laboratory services, recruitment, and consultancy. By combining these services within a single development platform, hVIVO supports pharmaceutical and biotechnology companies in generating high-quality data, optimising study execution, and advancing innovative respiratory therapies more efficiently.
Our Services
Clinical
hVIVO supports the full journey from preclinical to Phase III, transforming early Phase I data into clear direction for your product’s next steps. We enable fast success — or fast, informed failure — so you can make smarter decisions sooner.
Our integrated expertise includes:
-
Rapid delivery of safety data & insights through FiH/SAD/MAD/DDI studies in our clinical pharmacology unit combined with our biometry consultancy
-
Accelerate the PoC & efficacy data for your vaccine or anti-viral leveraging our globally recognised Human Challenge Trials using our world-class quarantine facility
-
Expert-led design, rapid recruitment and advanced diagnostic capabilities delivered through our sites in UK and Germany to advance your Phase II/III studies
Challenge
Building on decades of unrivalled experience, hVIVO is a leading CRO with world-class expertise in delivering human challenge trials, challenge agent manufacture, a unique portfolio of infectious and respiratory disease models, and specialist drug development and clinical consultancy services.
Labs
hVIVO has a highly specialised infectious disease and immunology laboratory offering a suite of services to support pre-clinical and drug and vaccine discovery & development.
hVIVO have extended their storage offering to the biotech and pharmaceutical industries with locations in London and Cambridge, offering a dedicated GxP storage facility for biological and clinical materials in secure temperature-controlled conditions.
Consulting
hVIVO's integrated drug development consultancy supports life science innovators from early planning through clinical execution. With more than 25-years of experience, our team delivers a uniquely combined offering across CMC, non-clinical, clinical pharmacology, regulatory, data management and (translational) laboratory services, across the drug development and market authorisation spectrum.
